Cargando…
In Silico Drug Prescription for Targeting Cancer Patient Heterogeneity and Prediction of Clinical Outcome
In silico drug prescription tools for precision cancer medicine can match molecular alterations with tailored candidate treatments. These methodologies require large and well-annotated datasets to systematically evaluate their performance, but this is currently constrained by the lack of complete pa...
Autores principales: | Piñeiro-Yáñez, Elena, Jiménez-Santos, María José, Gómez-López, Gonzalo, Al-Shahrour, Fátima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769767/ https://www.ncbi.nlm.nih.gov/pubmed/31540260 http://dx.doi.org/10.3390/cancers11091361 |
Ejemplares similares
-
An in silico analysis identifies drugs potentially modulating the cytokine storm triggered by SARS-CoV-2 infection
por: Sanchez-Burgos, Laura, et al.
Publicado: (2022) -
PanDrugs2: prioritizing cancer therapies using integrated individual multi-omics data
por: Jiménez-Santos, María José, et al.
Publicado: (2023) -
Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data
por: Fustero-Torre, Coral, et al.
Publicado: (2021) -
The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data
por: Fernández-Navarro, Pablo, et al.
Publicado: (2019) -
PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data
por: Piñeiro-Yáñez, Elena, et al.
Publicado: (2018)